Correction to Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1α Inhibitor Impairs Pancreatic Tumor Growth

ACS Nano. 2020 Jan 28;14(1):1211. doi: 10.1021/acsnano.0c00042. Epub 2020 Jan 13.
No abstract available

Publication types

  • Published Erratum